SOCRA CCRP Exam 2025 Update
|Actual Exam Set Questions And
Verified Answers (Correct solutions)
| Get It 100% Accurate!!
Save
Terms in this set (199)
April 30 1996 ICH GCP Development Date
Quality ICH Q
Efficacy ICH E
Safety ICH S
Multidisciplinary ICH M
guidance for ICH E 6
industry,
consolidated
guideance
,Clinical Safety ICH E2A
Data
Management
Definitions and
Standards
Safety ICH S7A
pharmacology
studies for human
pharmaceuticals
Electronic 21 CFR Part 11
records,
electronic
signatures
Informed 21 CFR Part 50
Consent
Financial 21 CFR Part 54
Disclosures
Institutional 21 CFR Part 56
Review Board
IND Application 21 CFR 312
New Drug 21 CFR 314
Application
,Investigational 21 CFR 812
Device
Exemption
pre market approval of medical
21 CFR Part 814
devices
45 CFR Part 46 Federal Research
Studies that Safety Pharmacology Studies (Pre-
investigate the Clinical)
potential
undesirable PD
effects of a
substance on
physiological
functions in
relation to
exposure in the
therapeutic range
or above
, 1) To Identify Drug Development Safety
undesirable PD Pharmacology Study Objectives (3)
properties of a
substance that
may have
relevance to its
human safety.
2) To evaluate
adverse PD
and/or
pathophysio
effects of a
substance
observed in
toxicology
studies
3)to investigate
the mechanism of
the adverse PD
effects observed
and/or suspected
1) Cardiovascular Three vital organ considered highest
2)Respiratory priority
3)CNS
|Actual Exam Set Questions And
Verified Answers (Correct solutions)
| Get It 100% Accurate!!
Save
Terms in this set (199)
April 30 1996 ICH GCP Development Date
Quality ICH Q
Efficacy ICH E
Safety ICH S
Multidisciplinary ICH M
guidance for ICH E 6
industry,
consolidated
guideance
,Clinical Safety ICH E2A
Data
Management
Definitions and
Standards
Safety ICH S7A
pharmacology
studies for human
pharmaceuticals
Electronic 21 CFR Part 11
records,
electronic
signatures
Informed 21 CFR Part 50
Consent
Financial 21 CFR Part 54
Disclosures
Institutional 21 CFR Part 56
Review Board
IND Application 21 CFR 312
New Drug 21 CFR 314
Application
,Investigational 21 CFR 812
Device
Exemption
pre market approval of medical
21 CFR Part 814
devices
45 CFR Part 46 Federal Research
Studies that Safety Pharmacology Studies (Pre-
investigate the Clinical)
potential
undesirable PD
effects of a
substance on
physiological
functions in
relation to
exposure in the
therapeutic range
or above
, 1) To Identify Drug Development Safety
undesirable PD Pharmacology Study Objectives (3)
properties of a
substance that
may have
relevance to its
human safety.
2) To evaluate
adverse PD
and/or
pathophysio
effects of a
substance
observed in
toxicology
studies
3)to investigate
the mechanism of
the adverse PD
effects observed
and/or suspected
1) Cardiovascular Three vital organ considered highest
2)Respiratory priority
3)CNS
